Research Article
Old Is (Not) Gold: Midazolam Monotherapy versus Midazolam Plus Fentanyl for Sedation during Cardiac Catheterization
Table 1
Baseline characteristics by group.
| Variable | M N = 69 | M + F N = 60 | value |
| Age | 66.17 (10.18) | 63.87 (12.70) | 0.50 | BMI | 30.03 (6.86) | 32.03 (6.42) | 0.09 | Gender (female), n (%) | 15 (21.74%) | 26 (43.33%) | 0.008 | CAD | 38 (55.07%) | 27 (45%) | 0.44 | CHF | 10 (14.49%) | 6 (10%) | 0.44 | HLD | 51 (73.91%) | 40 (66.67%) | 0.37 | DM | 17 (24.64%) | 19 (31.67%) | 0.38 | PVD | 5 (7.25%) | 3 (5%) | 0.60 | HTN | 55 (79.71%) | 49 (81.67%) | 0.78 | Tobacco use | 23 (33.33%) | 13 (21.67%) | 0.14 | CKD | 8 (11.59%) | 4 (6.67%) | 0.34 | UA | 2 (2.90%) | 1 (1.67%) | 0.65 | Chronic pain | 6 (8.70%) | 6 (10%) | 0.80 |
|
|
Values are mean (standard deviation). Values are frequency (percentage). , . M, midazolam group; M + F, midazolam plus the fentanyl group. |